NASDAQ · Financial Statements

Deep Medicine Acquisition Corp. (DMAQ) Financial Statements

$2.96 NASDAQ: DMAQ Market Cap $12.90M

Deep Medicine Acquisition Corp. most recently reported annual revenue of $19.0M, net profit of $-15.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20202021202220242025
Revenue—$0$0$22.0M$19.0M
Operating Profit—$0$0$-2.0M$-6.0M
Net Profit—$0$0$-9.0M$-15.0M
EPS—$-0.04$-0.04$-0.76$-51.39
Op Margin———-9.6%-32.3%

Balance Sheet (USD)

Metric20202021202220242025
Total Assets$1.0M$129.0M$10.0M$17.0M$20.0M
Total Liabilities$1.0M$5.0M$7.0M$22.0M$16.0M
Cash$1.0M$1.0M$1.0M$11.0M$10.0M
Borrowings$1.0M$1.0M$2.0M$11.0M$6.0M

Cash Flow (USD)

Metric20202021202220242025
Operating Cash Flow—$-1.0M$-1.0M$-4.0M$-2.0M
Investing Cash Flow—$-128.0M$120.0M$1.0M$-4.0M
Financing Cash Flow—$129.0M$-241.0M$9.0M$11.0M
Net Cash Flow—$0$0$5.0M$2.0M
Free Cash Flow$0$-1.0M$-1.0M$-4.0M$-2.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA5.53
FCF Yield-14.76%
Quick Ratio1.01
Interest Coverage1.87
Return 1Y—
Return 3Y—
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Financial Services StocksLow P/E Financial Services StocksHigh Net Margin Financial Services StocksDividend Financial Services StocksLow Debt Financial Services StocksNasdaq High ROE StocksAll stock screens
DMAQ Overview DMAQ Dividend Run Stock Screener